Chris Wagner

Chris Wagner

Director Ejecutivo en
Immunoflex Therapeutics, Inc.
.
57 años
Health Technology
Consumer Services
Industrial Services

Perfil

Chris Wagner was the founder of Canexia Health, Inc. (Canada), founded in 2012, where the title held was Chief Executive Officer.
Mr. Wagner is also the founder of Aspreva Pharmaceuticals Corp.,Immunoflex Therapeutics, Inc...
Mr. Wagner currently holds the position of Director at Contextual Health since 2019.
Mr. Wagner also serves as Area Manager-New Mexico at Meridian Engineering Co. Former positions include President & Chief Executive Officer at Sirius Genomics, Inc., Director at Emerald Health Therapeutics, Inc. from 2018 to 2019, Independent Director at Filament Health Corp.
from 2021 to 2024, and Principal at Eli Lilly & Co. Education includes undergraduate studies at the University of British Columbia.

Cargos activos de Chris Wagner

EmpresasCargoInicio
Director/Miembro de la Junta 01/05/2019
Corporate Officer/Principal -
Immunoflex Therapeutics, Inc.
Director Ejecutivo -

Antiguos cargos conocidos de Chris Wagner.

EmpresasCargoFin
FILAMENT HEALTH CORP. Director/Miembro de la Junta 01/04/2024
EMERALD HEALTH THERAPEUTICS Director Ejecutivo 28/11/2018
Director Ejecutivo -
Fundador -
ELI LILLY AND COMPANY Corporate Officer/Principal -
Ver el detalle de la experiencia de Chris Wagner.

Formación de Chris Wagner.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Relaciones

8

Relaciones de 1er grado

10

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Empresas relacionadas

Empresas privadas10

Health Technology

Health Technology

Consumer Services

Health Technology

Industrial Services

Process Industries

Health Technology

Health Technology

Immunoflex Therapeutics, Inc.

Health Services